Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,966
Closed -$645K 946
2024
Q1
$645K Buy
1,966
+435
+28% +$131K ﹤0.01% 787
2023
Q4
$429K Sell
1,531
-1,200
-44% -$300K ﹤0.01% 888
2023
Q3
$616K Sell
2,731
-4,044
-60% -$876K ﹤0.01% 751
2023
Q2
$1.5M Sell
6,775
-132
-2% -$26.4K 0.01% 709
2023
Q1
$1.44M Buy
6,907
+1,459
+27% +$296K 0.01% 782
2022
Q4
$968K Sell
5,448
-3,408
-38% -$606K ﹤0.01% 865
2022
Q3
$1.48M Sell
8,856
-2,086
-19% -$388K 0.01% 819
2022
Q2
$2M Buy
10,942
+3,305
+43% +$616K 0.01% 815
2022
Q1
$1.48M Buy
+7,637
New +$1.56M 0.01% 919

Other funds holding KAI

Aviva's KAI Position: Q2 2024 in Review

Aviva sold out of Kadant (KAI) in Q2 2024, closing a stake of 1,966 shares — an estimated $645K sold.

Aviva first reported a position in KAI in Q1 2022 and held it in 9 quarters. The position peaked at $2M in Q2 2022. 257 funds tracked by Wall St. Rank hold KAI as of Q2 2024.

  • Aviva reported no remaining Kadant position as of Q2 2024 after selling out during the quarter.
  • Aviva sold 1,966 Kadant shares in Q2 2024, an estimated $645K.
  • Aviva first reported a position in Kadant in Q1 2022 and held it in 9 quarters.
  • Aviva's Kadant position peaked at $2M in Q2 2022.
  • 257 funds tracked by Wall St. Rank held Kadant as of Q2 2024.

Based on Aviva's 13F filing for Q2 2024, filed 2 Aug 2024.